News | July 06, 2010

$10.6 Million Center Established to Study New MRI Technology

July 6, 2010 – The development of a new magnetic resonance imaging (MRI) technology, which may revolutionize the way medical conditions are diagnosed and treated, is to take a major step forward as a $10.6 million research center is established at the University of York.

Hyperpolarization with parahydrogen is a technique developed at the university that can dramatically increase the sensitivity of MRIs. It is hoped hyperpolarization will eventually be used to help doctors make diagnoses in minutes that currently take days and tailor treatments more accurately to the needs of individual patients.

The research team, led by professors Simon Duckett and Gary Green, of the departments of chemistry and psychology respectively, has secured a grant from the Wellcome Trust and Wolfson Foundation, as well as financial support from industrial partners and the university, to build the York Centre for Hyperpolarisation in Magnetic Resonance Imaging.

“Although MRI is already an incredibly useful technique, its sensitivity is in fact very low, rather like finding a needle in a haystack, which makes it difficult to detect the early stages of disease. It can also be very slow, limiting the way MRI is used in clinical settings,” Duckett said.

The York Centre will bring together researchers from across the departments of chemistry, psychology, biology and the Hull York Medical School to develop this technology. The team will also be working with professor Jürgen Hennig of the University Hospital Freiburg, one of the world’s leading experts in the medical application of MRI technology.

Hyperpolarization involves transferring the magnetism of parahydrogen to molecules, making them more visible to nuclear magnetic resonance, an important research tool in chemistry, and magnetic resonance imaging. The new center’s early research program will develop the chemical basis of this method to make it suitable for medical applications.

Related Content

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Magnetic Resonance Imaging (MRI)| August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
GE Healthcare's Signa Premier MRI Receives FDA 510(k) Clearance
Technology | Magnetic Resonance Imaging (MRI)| August 04, 2017
GE Healthcare announced Signa Premier, a new wide bore 3.0T magnetic resonance imaging (MRI) system, is now available...
Cardiac CT scan showing plaque and calcification in the coronary arteries, from a Toshiba CT scanner
News | Business| July 19, 2017
July 19, 2017 — The Society of Cardiovascular Computed Tomography (SCCT) created a reimbursement fee chart for cardia
German Workshop Highlights Possibilities of Perfusion MRI
News | Stroke| July 03, 2017
When diagnosing strokes and heart diseases or looking at tumors, perfusion magnetic resonance imaging (MRI) offers a...
Sponsored Content | Videos | Clinical Decision Support| June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
Toshiba Medical Introduces Vantage Titan Zen Edition MR
Technology | Magnetic Resonance Imaging (MRI)| June 27, 2017
June 27, 2017 — Toshiba Medical, a Canon Group company, introduced its newest...
HRS released a consensus statement on MRI for patients with cardiac implantable electronic devices
Feature | May 15, 2017
May 15, 2017 — The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement in the United States o
Biotronik Launches First FDA-Approved CRM Devices with MRI AutoDetect Technology
Technology | Cardiac Resynchronization Therapy Devices (CRT)| May 10, 2017
Biotronik announced the availability of the first U.S. Food and Drug Administration (FDA)-approved cardiac rhythm...
Overlay Init